3 explosive healthcare shares to give your portfolio a boost

Impedimed Limited (ASX:IPD) and two other shares could have bright futures ahead of them. Is it time you invested?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the best performing areas of the market so far this year has been the healthcare sector. Even after a sharp decline yesterday the S&P/ASX 200 Health Care (Index: ^AXHJ) (ASX: XHJ) index is still up 3.6% for the year.

Considering the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is now down 1.4% year to date, healthcare has clearly been a great place to put your money. But have investors missed out on all the gains now? I don't think they have. I believe these three healthcare shares could prove to be great long-term investments today.

Impedimed Limited (ASX: IPD)

This growing medical device company is one to keep a close eye on. ImpediMed recently launched its first product into the health and wellness market. Its SOZO device allows users to track everything from their body composition, fluid status, and hydration levels through a variety of settings. As well as this the company commenced with the full commercial launch of its L-Dex lymphoedema detection product in the US marketplace and began to pursue the Chronic Heart Failure business. According to management ImpediMed has been attracting the attention and support of some of the most prestigious medical organisations in the United States. One in particular is Mayo Clinic which wants to work with the company to explore new opportunities for its technology.

Monash IVF Group Ltd (ASX: MVF)

As well as providing investors with growth at a reasonable price, this leading fertility treatment company also provides investors with a fully franked 3.9% dividend. In its recent full year results the company posted a 12.4% jump in IVF treatments, outpacing the industry average of 8.2% and increasing its market share to almost 24%. This led to a 34.6% increase in full year net profit after tax to $28.8 million. With management expecting demand for its services to continue to increase, I believe Monash IVF represents a great investment today.

REVA Medical Inc (ASX: RVA)

Thanks to the development of REVA Medical's bioresorbable scaffolds I feel this is a company with enormous potential. The company aims for its scaffolds to one day replace the traditional metal stents used to treat coronary artery disease currently. Unlike metal stents which stay in the artery permanently, REVA Medical's scaffolds are designed to disappear naturally when their job is done. Clinical trials have been very positive and the company is now in the process of seeking regulatory approval. If the company can get a foothold in a market expected to be worth $8.3 billion by 2019, it could have a very bright future ahead of it.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »